Sharekhan's research report on Wipro
Wipro delivered broadly in-line constant currency revenue growth; EBIT margin surprised positively. Management expects the headwinds in healthcare and India business to recede in next few quarters. Q4FY19 revenue growth guidance of 0-2%, below our expectations; Guidance bakes in lower enrolments in healthcare and macro uncertainties.
Outlook
We retain our Buy rating on the stock of Wipro with an unchanged price target of Rs 390.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
